Skip to main content
. 2019 Sep 7;15(11):2497–2508. doi: 10.7150/ijbs.37481

Figure 4.

Figure 4

Xanthohumol inhibits EGFR signaling in colorectal cancer cells. A, HCT116 and HT29 cells were treated with different doses of xanthohumol and harvested for IB analysis. B, HCT116 and HT29 cells were serum-starved overnight, then pre-treated with various doses of xanthohumol for 2 h, treated with EGF for 30 min and harvested for IB analysis. C, HCT116 and HT29 cells were serum-starved overnight, then pre-treated with 4 μM xanthohumol for 2 h, and treated with EGF for different time points. Cell lysates were harvested for IB analysis.